Matthew C. Hill, Chief Financial Officer at Apyx Medical Corp (APYX), bought 6,000 shares at $1.13 ($7K) on 2024-08-13, disclosed to the SEC on 2025-03-03.
Open-market purchase of $7k APYX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| PDSB | BUY | 2021-12-14 | $27K | — | Filing → |
| SSKN | BUY | 2018-06-14 | $20K | — | Filing → |
| VLCR | BUY | 2008-05-28 | $4K | — | Filing → |